Shares of CureVac BV (NASDAQ:CVAC) fell by 12.3% to $4.10 Wednesday afternoon. The pullback could be due to profit-taking after Tuesday's strong gains, which were fueled by heightened concerns over respiratory illnesses across the U.S.
The surge in healthcare visits, driven by higher cases of seasonal influenza, COVID-19 and RSV, has renewed interest in vaccine and therapeutic manufacturers this week.
Read Also: US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
What Else: CureVac’s pipeline includes second-generation mRNA vaccines targeting COVID-19 and seasonal influenza, developed in collaboration with GSK. These vaccines aim to offer enhanced efficacy, stability and manufacturing scalability compared to first-generation mRNA platforms.
The company's commitment to pioneering mRNA solutions could position it as a key competitor in the global biotechnology landscape.
Read Also: Wall Street Mixed Ahead Of Fed Minutes, Dollar Bolsters Strength, Bitcoin Falls Below $95,000: What’s Driving Markets Wednesday?
How To Buy CVAC Stock
By now you're likely curious about how to participate in the market for CureVac – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
According to data from Benzinga Pro, CVAC has a 52-week high of $5.28 and a 52-week low of $2.22.
